Jonas Schoendube
Direttore/Membro del Consiglio presso Cytena Bioprocess Solutions
Posizioni attive di Jonas Schoendube
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| Cytena Bioprocess Solutions | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Jonas Schoendube
Precedenti posizioni note di Jonas Schoendube
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
cytena GmbH
 cytena GmbH BiotechnologyHealth Technology cytena GmbH develops a device for separating of single cells. It has developed a device called cy-Clone to separate single cells and these single cells are required for the development of state-of-the-art drugs, so-called biologicals as well as for the genetic analysis of single cells for cancer and stem cell research, the cy-Clone is supported by an automated imaging process to encapsulate cells in droplets, which are delivered to any type of substrate. The company was founded by Peter Koltay, Benjamin Steimle, Jonas Schoendube and Andre Gross in August 2014 and is headquartered in Freiburg, Germany. | Amministratore Delegato | 01/06/2014 | 01/05/2021 |
| Fondatore | 01/06/2014 | 01/05/2021 | |
| BICO GROUP AB | Corporate Officer/Principal | 01/01/2020 | - |
Formazione di Jonas Schoendube
| University of Freiburg | Doctorate Degree |
| Swiss Federal Institute of Technology | Graduate Degree |
Statistiche
Distribuzione geografica
| Germania | 3 |
| Svizzera | 2 |
| Svezia | 2 |
Posizioni
| Chief Executive Officer | 1 |
| Founder | 1 |
| Corporate Officer/Principal | 1 |
Settori
| Consumer Services | 3 |
| Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| BICO GROUP AB | Health Technology |
| Aziende private | 2 |
|---|---|
cytena GmbH
cytena GmbH BiotechnologyHealth Technology cytena GmbH develops a device for separating of single cells. It has developed a device called cy-Clone to separate single cells and these single cells are required for the development of state-of-the-art drugs, so-called biologicals as well as for the genetic analysis of single cells for cancer and stem cell research, the cy-Clone is supported by an automated imaging process to encapsulate cells in droplets, which are delivered to any type of substrate. The company was founded by Peter Koltay, Benjamin Steimle, Jonas Schoendube and Andre Gross in August 2014 and is headquartered in Freiburg, Germany. | Health Technology |
| Cytena Bioprocess Solutions |
- Borsa valori
- Insiders
- Jonas Schoendube
- Esperienza
